Lobbying pays off drugmaker in bill
WASHINGTON (AP) A provision tucked into the massive congressional budget bill will benefit a small pharmaceutical company in Washington state.
Lawmakers acted after a lobbying campaign by Omeros, which makes a drug for cataract surgery, and stepped-up political contributions from people associated with the company.
The provision props up the price Medicare pays for that drug, as well as a handful of products from other firms.
Aides said Rep. Cathy McMorris Rodgers of Washington, the fourth-ranking House Republican, took the issue to Speaker Paul Ryan, securing a place for the drug provision in the spending bill signed Friday by President Donald Trump.